Searchable abstracts of presentations at key conferences in endocrinology

ea0016p287 | Endocrine tumours | ECE2008

The role of 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG/PET-CT) in the follow-up of differentiated thyroid cancer (DTC)

Pagano Loredana , Klain Michele , Pulcrano Melania , Ippolito Serena , Lombardi Gaetano , Salvatore Marco , Biondi Bernadette

Aim: To address the role of FDG/PET-CT in the follow-up of DTC.Methods: About 110 consecutive patients (86 female, 24 male, mean age 45±13 years), with DTC were selected between 1999 and 2006. All patients underwent total thyroidectomy, radioiodine ablation and had undetectable serum thyroglobulin (Tg) during L-T4 suppressive therapy and negative serum TgAb. The follow-up included a yearly clinical examination with n...

ea0014p178 | (1) | ECE2007

The use of 18F-FDG PET/CT with or without rhTSH stimulation during follow-up of patients with differentiated thyroid carcinoma

Lupoli Gelsy Arianna , Panico Annalisa , Colarusso Sara , Fonderico Francesco , Gonnella Antonio , Poggiano Maria Rita , Pucci Luigi , Martinelli Addolorata , Nicolai Emanuele , Salvatore Marco , Lupoli Giovanni

Background: Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) is a new method employed in the management of differentiated thyroid cancer (DTC). The integrated FDG-PET plus computed tomography (PET/CT) fusion imaging system seems able to provide some additional advantages over PET alone, mainly related to a better anatomical localisation of the hypermetabolic metastatic lesions. The influence of serum TSH levels on 18F-FDG uptake by recurrences o...